Evidence map›Paper›PMID 38722804›Full record

GuidelineThe British journal of surgery2024

Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision.

Gloria Zaffaroni, Alessandro Mannucci, Laura Koskenvuo, Borja de Lacy, Anna Maffioli, Tanya Bisseling, Elizabeth Half, Giulia Martina Cavestro, Laura Valle, Neil Ryan and 29 more

Erratum issued 2 registry-linked trialsAbstract readPractice GuidelineSystematic Review
In one paragraph

Guideline in The British journal of surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07199127 recruitingnot on this map

Novel Endoscopic Classification for Duodenal Polyposis in Individuals With Familial Adenomatous Polyposis

TypeobservationalSponsorFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRan2018 to 2030Enrolled300ConditionsDuodenum Cancer, Familial Adenomatous Polyposis, Duodenal Polyposis, Ampulla of Vater AdenomaArmsDRACO
NCT07700992 recruitingnot on this mapstarted 2026, after this paper: background citation

An Exosome-based and Machine-learning-powered Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring

TypeobservationalSponsorUniversità Vita-Salute San RaffaeleRan2026 to 2032Enrolled600ConditionsFamilial Pancreatic Cancer, Familial Pancreatic Carcinoma, Hereditary Pancreatic Cancer, Hereditary PancreatitisArmsPANXEON
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Adenomatous Polyposis Coli Gene Polyposis-Related Syndromes.The American journal of gastroenterology · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors.

Gloria ZaffaroniCenter for Hereditary Tumors, Bethesda Hospital, Duisburg, Germany.ORCID 0000-0002-1831-3107
Alessandro MannucciGastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0002-1655-6762
Laura KoskenvuoDepartment of Gastroenterological Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.ORCID 0000-0001-8335-7942
Borja de LacyDepartment of Gastrointestinal Surgery, Hospital Clinic of Barcelona, Barcelona, Spain.ORCID 0000-0002-1485-7668
Anna MaffioliFaculty of Medicine and Surgery, University of Milan, Milan, Italy.
Tanya BisselingDepartment of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Elizabeth HalfCancer Prevention and Hereditary GI Cancer Unit, Rambam Health Care Campus, Haifa, Israel.
Giulia Martina CavestroGastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-1947-9368
Laura ValleHereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, IDIBELL, Barcelona, Spain.
Neil RyanThe College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
Stefan AretzInstitute of Human, Genetics, Medical Faculty, University of Bonn and National Center for Hereditary Tumour Syndromes, University Hospital Bonn, Bonn, Germany.
Karen BrownLeicester Cancer Research Centre, University of Leicester, Leicester, UK.
Francesco ButtittaDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Fatima CarneiroFaculty of Medicine of Porto University, Centro Hospitalar Universitário de São João, Ipatimup, Porto, Portugal.
Oonagh ClaberDepartment of Clinical Genetics, Northern Genetics Service, Newcastle upon Tyne, UK.
Ruth Blanco-ColinoDepartment of Gastrointestinal Surgery, Vall d'Hebron University Hospital, Barcelona, Spain.
Maxime CollardDepartment of Digestive Surgery, Hôpital Saint-Antoine, Sorbonne University, APHP, Paris, France.ORCID 0000-0002-7882-6860
Emma CrosbieDivision of Cancer Sciences, University of Manchester, Manchester, UK.
Miguel CunhaDepartment of Surgery, Algarve Universitary Hospital Center, Colorectal SurgeryGroup, Portimao, Portugal.
Triantafyllos DouliasDepartment of Colorectal Surgery, Colchester Hospital, East Suffolk and North Essex NHS Foundation Trust, Colchester, UK.
Christina FlemingDepartment of Colorectal Surgery, University Hospital Limerick, Limerick, Ireland.
Henriette HeinrichDepartment for Gastroenterology and Hepatology, Clarunis Universitäres Bauchzentrum, Universitätsspital Basel, Basel, Switzerland.
Robert HüneburgDepartment of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
Julie MetrasDepartment of Digestive Surgery, Hôpital Saint-Antoine, Sorbonne University, APHP, Paris, France.
Iris NagtegaalDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Ionut NegoiDepartment of General Surgery, Carol Davila University of Medicine and Pharmacy Bucharest, Emergency Hospital of Bucharest, Bucharest, Romania.ORCID 0000-0002-6950-9599
Maartje NielsenClinical Genetics Department, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-5351-1870
Gianluca PellinoDepartment of Gastrointestinal Surgery, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0002-8322-6421
Luigi RicciardielloDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Abdurrahman SagirCenter for Hereditary Tumors, Bethesda Hospital, Duisburg, Germany.
Luis Sánchez-GuillénDepartment of Gastrointestinal Surgery, Elche General University Hospital, Elche, Alicante, Spain.ORCID 0000-0003-0623-9074
Toni T SeppäläDepartment of Gastroenterological Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Peter SiersemaDepartment of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Benedikt StriebeckSupport Group Polyposis Coli e.V., FAP Patient, Germany.
Julian R SampsonInstitute of Medical Genetics, Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.
Andrew LatchfordPolyposis Registry, St Mark's Hospital, Harrow, UK.
Yann ParcDepartment of Digestive Surgery, Hôpital Saint-Antoine, Sorbonne University, APHP, Paris, France.
John BurnNewcastle University Translational and Clinical Research Institute, Centre for Life, Newcastle upon Tyne, UK.
Gabriela MösleinCenter for Hereditary Tumors, Bethesda Hospital, Duisburg, Germany.ORCID 0000-0002-0639-8350

Funding

British Journal of MedicineCancer Research UK 15934European Society of Coloproctology
6 · The paper itself

Abstract

backgroundHereditary adenomatous polyposis syndromes, including familial adenomatous polyposis and other rare adenomatous polyposis syndromes, increase the lifetime risk of colorectal and other cancers.

methodsA team of 38 experts convened to update the 2008 European recommendations for the clinical management of patients with adenomatous polyposis syndromes. Additionally, other rare monogenic adenomatous polyposis syndromes were reviewed and added. Eighty-nine clinically relevant questions were answered after a systematic review of the existing literature with grading of the evidence according to Grading of Recommendations, Assessment, Development, and Evaluation methodology. Two levels of consensus were identified: consensus threshold (≥67% of voting guideline committee members voting either 'Strongly agree' or 'Agree' during the Delphi rounds) and high threshold (consensus ≥ 80%).

resultsOne hundred and forty statements reached a high level of consensus concerning the management of hereditary adenomatous polyposis syndromes.

conclusionThese updated guidelines provide current, comprehensive, and evidence-based practical recommendations for the management of surveillance and treatment of familial adenomatous polyposis patients, encompassing additionally MUTYH-associated polyposis, gastric adenocarcinoma and proximal polyposis of the stomach and other recently identified polyposis syndromes based on pathogenic variants in other genes than APC or MUTYH. Due to the rarity of these diseases, patients should be managed at specialized centres.

Indexed as

AdenocarcinomaAdenomatous Polyposis ColiDNA GlycosylasesStomach NeoplasmsAdenomatous PolypsEuropeHumansNeoplastic Syndromes, HereditaryPolypsDNA GlycosylasesmutY adenine glycosylase

Identifiers

PMID38722804
PMCPMC11081080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.